Interpace Biosciences, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | 34.4% | -109.1% | -110.4% |
| FY2020 | 33.1% | -80.5% | -81.6% |
| FY2021 | 229.4% | -77.3% | -182.3% |
| FY2022 | 321.1% | -63.7% | -386.7% |
| FY2023 | 62.6% | 9.9% | 4.9% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2019 | 34.4% | -109.1% | -110.4% |
| FY2020 | 33.1% | -80.5% | -81.6% |
| FY2021 | 229.4% | -77.3% | -182.3% |
| FY2022 | 321.1% | -63.7% | -386.7% |
| FY2023 | 62.6% | 9.9% | 4.9% |